Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Skanska B SKAB Apr 25, 2025 215.90 +1.50   
 SKF A SKFA Apr 25, 2025 187.50 +1.63   
 SKF B SKFB Apr 25, 2025 186.00 +1.53   
 SkiStar B SKISB Apr 25, 2025 167.40 +0.30   
 Skolon AB SKOLON Apr 25, 2025 30.00 -0.33   
 Skåne-möllan SKMO Apr 25, 2025 59.20 +6.86   
 Sleep Cycle SLEEP Apr 25, 2025 33.50 -18.09   
 Slottsviken B SLOTTB Apr 25, 2025 41.40 -0.96   
 Smart Eye SEYE Apr 25, 2025 57.15 +0.26   
 Smoltek SMOL Apr 25, 2025 0.46 -0.22   
 Sociallite US SOCIAL Apr 25, 2025 0.46 +2.22   
 Softronic B SOFB Apr 25, 2025 23.45 +2.40   
 Solid Försäkring SFAB Apr 25, 2025 78.70 -1.25   
 SolidX SOLIDX Apr 25, 2025 1.55 +4.73   
 Solnaberg Property SOLNA Apr 25, 2025 120.00 +2.56   
 SolTech Energy Sweden SOLT Apr 25, 2025 2.76 +4.94   
 Sonetel SONE Apr 25, 2025 4.42 0.00   
 Sotkamo Silver SOSI Apr 25, 2025 1.20 +2.56   
 Sound Dimension SOUND Apr 25, 2025 1.31 -0.76   
 Sozap SOZAP Apr 25, 2025 0.47 +3.74   
 Spago Nanomedical SPAGO Apr 25, 2025 0.22 -1.37   
 SpectraCure AB SPEC Apr 25, 2025 1.78 0.00   
 SpectrumOne SPEONE Apr 25, 2025 0.27 -0.37   
 Spermosens SPERM Apr 25, 2025 0.01 +2.56   
 Sperrung SPERR Apr 25, 2025 0.07 0.00   
 Spiffbet SPIFF Apr 25, 2025 1.41 -7.24   
 Spiltan Invest SPLTN Apr 25, 2025 209.50 +1.45   
 Spotlight Group SPGR Apr 25, 2025 20.00 0.00   
 Sprint Bioscience SPRINT Apr 25, 2025 0.66 0.00   
 SSAB A SSABA Apr 25, 2025 60.10 +0.37   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.